Peptide fragment of LYVE-1 and antibody against the same

Details for Australian Patent Application No. 2004220209 (hide)

Owner Teikoku Hormone Mfg. Co., Ltd.

Inventors Ishii, Toshiharu; Ito, Kinji; Akishima, Yuri

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004220209

PCT Pub. Number WO2004/081035

Priority 2003-070568 14.03.03 JP

Filing date 11 March 2004

Wipo publication date 23 September 2004

International Classifications

C07K 007/08 Peptides having 5 to 20 amino acids in a fully defined sequence

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 014/705 Peptides having more than 20 amino acids

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/081035 Priority application(s): WO2004/081035

20 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220212-Protein kinase inhibitors

2004220205-Antitumor effect potentiator and antitumor agent